+1 347 708 0418
Mucopolysaccharidosis (MPS) Treatment market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Mucopolysaccharidosis (MPS) Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Stem Cell Therapies
Enzyme Replacement Therapies
Segment by Application
Hospitals
Clinics
Homecare
By Company
Sanofi
Shire (Takeda)
BioMarin Pharmaceutical
Esteve
REGENXBIO Inc
Sangamo Therapeutics
Ultragenyx Pharmaceutical
Abeona Therapeutics
ArmaGen
Eloxx Pharmaceuticals
Inventiva
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Mucopolysaccharidosis (MPS) Treatment Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Stem Cell Therapies
1.2.3 Enzyme Replacement Therapies
1.3 Market by Application
1.3.1 Global Mucopolysaccharidosis (MPS) Treatment Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Homecare
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Mucopolysaccharidosis (MPS) Treatment Market Perspective (2017-2028)
2.2 Mucopolysaccharidosis (MPS) Treatment Growth Trends by Region
2.2.1 Mucopolysaccharidosis (MPS) Treatment Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Mucopolysaccharidosis (MPS) Treatment Historic Market Size by Region (2017-2022)
2.2.3 Mucopolysaccharidosis (MPS) Treatment Forecasted Market Size by Region (2023-2028)
2.3 Mucopolysaccharidosis (MPS) Treatment Market Dynamics
2.3.1 Mucopolysaccharidosis (MPS) Treatment Industry Trends
2.3.2 Mucopolysaccharidosis (MPS) Treatment Market Drivers
2.3.3 Mucopolysaccharidosis (MPS) Treatment Market Challenges
2.3.4 Mucopolysaccharidosis (MPS) Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Mucopolysaccharidosis (MPS) Treatment Players by Revenue
3.1.1 Global Top Mucopolysaccharidosis (MPS) Treatment Players by Revenue (2017-2022)
3.1.2 Global Mucopolysaccharidosis (MPS) Treatment Revenue Market Share by Players (2017-2022)
3.2 Global Mucopolysaccharidosis (MPS) Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Mucopolysaccharidosis (MPS) Treatment Revenue
3.4 Global Mucopolysaccharidosis (MPS) Treatment Market Concentration Ratio
3.4.1 Global Mucopolysaccharidosis (MPS) Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Mucopolysaccharidosis (MPS) Treatment Revenue in 2021
3.5 Mucopolysaccharidosis (MPS) Treatment Key Players Head office and Area Served
3.6 Key Players Mucopolysaccharidosis (MPS) Treatment Product Solution and Service
3.7 Date of Enter into Mucopolysaccharidosis (MPS) Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Mucopolysaccharidosis (MPS) Treatment Breakdown Data by Type
4.1 Global Mucopolysaccharidosis (MPS) Treatment Historic Market Size by Type (2017-2022)
4.2 Global Mucopolysaccharidosis (MPS) Treatment Forecasted Market Size by Type (2023-2028)
5 Mucopolysaccharidosis (MPS) Treatment Breakdown Data by Application
5.1 Global Mucopolysaccharidosis (MPS) Treatment Historic Market Size by Application (2017-2022)
5.2 Global Mucopolysaccharidosis (MPS) Treatment Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Mucopolysaccharidosis (MPS) Treatment Market Size (2017-2028)
6.2 North America Mucopolysaccharidosis (MPS) Treatment Market Size by Type
6.2.1 North America Mucopolysaccharidosis (MPS) Treatment Market Size by Type (2017-2022)
6.2.2 North America Mucopolysaccharidosis (MPS) Treatment Market Size by Type (2023-2028)
6.2.3 North America Mucopolysaccharidosis (MPS) Treatment Market Share by Type (2017-2028)
6.3 North America Mucopolysaccharidosis (MPS) Treatment Market Size by Application
6.3.1 North America Mucopolysaccharidosis (MPS) Treatment Market Size by Application (2017-2022)
6.3.2 North America Mucopolysaccharidosis (MPS) Treatment Market Size by Application (2023-2028)
6.3.3 North America Mucopolysaccharidosis (MPS) Treatment Market Share by Application (2017-2028)
6.4 North America Mucopolysaccharidosis (MPS) Treatment Market Size by Country
6.4.1 North America Mucopolysaccharidosis (MPS) Treatment Market Size by Country (2017-2022)
6.4.2 North America Mucopolysaccharidosis (MPS) Treatment Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Mucopolysaccharidosis (MPS) Treatment Market Size (2017-2028)
7.2 Europe Mucopolysaccharidosis (MPS) Treatment Market Size by Type
7.2.1 Europe Mucopolysaccharidosis (MPS) Treatment Market Size by Type (2017-2022)
7.2.2 Europe Mucopolysaccharidosis (MPS) Treatment Market Size by Type (2023-2028)
7.2.3 Europe Mucopolysaccharidosis (MPS) Treatment Market Share by Type (2017-2028)
7.3 Europe Mucopolysaccharidosis (MPS) Treatment Market Size by Application
7.3.1 Europe Mucopolysaccharidosis (MPS) Treatment Market Size by Application (2017-2022)
7.3.2 Europe Mucopolysaccharidosis (MPS) Treatment Market Size by Application (2023-2028)
7.3.3 Europe Mucopolysaccharidosis (MPS) Treatment Market Share by Application (2017-2028)
7.4 Europe Mucopolysaccharidosis (MPS) Treatment Market Size by Country
7.4.1 Europe Mucopolysaccharidosis (MPS) Treatment Market Size by Country (2017-2022)
7.4.2 Europe Mucopolysaccharidosis (MPS) Treatment Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Mucopolysaccharidosis (MPS) Treatment Market Size (2017-2028)
8.2 Asia-Pacific Mucopolysaccharidosis (MPS) Treatment Market Size by Type
8.2.1 Asia-Pacific Mucopolysaccharidosis (MPS) Treatment Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Mucopolysaccharidosis (MPS) Treatment Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Mucopolysaccharidosis (MPS) Treatment Market Share by Type (2017-2028)
8.3 Asia-Pacific Mucopolysaccharidosis (MPS) Treatment Market Size by Application
8.3.1 Asia-Pacific Mucopolysaccharidosis (MPS) Treatment Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Mucopolysaccharidosis (MPS) Treatment Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Mucopolysaccharidosis (MPS) Treatment Market Share by Application (2017-2028)
8.4 Asia-Pacific Mucopolysaccharidosis (MPS) Treatment Market Size by Region
8.4.1 Asia-Pacific Mucopolysaccharidosis (MPS) Treatment Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Mucopolysaccharidosis (MPS) Treatment Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Mucopolysaccharidosis (MPS) Treatment Market Size (2017-2028)
9.2 Latin America Mucopolysaccharidosis (MPS) Treatment Market Size by Type
9.2.1 Latin America Mucopolysaccharidosis (MPS) Treatment Market Size by Type (2017-2022)
9.2.2 Latin America Mucopolysaccharidosis (MPS) Treatment Market Size by Type (2023-2028)
9.2.3 Latin America Mucopolysaccharidosis (MPS) Treatment Market Share by Type (2017-2028)
9.3 Latin America Mucopolysaccharidosis (MPS) Treatment Market Size by Application
9.3.1 Latin America Mucopolysaccharidosis (MPS) Treatment Market Size by Application (2017-2022)
9.3.2 Latin America Mucopolysaccharidosis (MPS) Treatment Market Size by Application (2023-2028)
9.3.3 Latin America Mucopolysaccharidosis (MPS) Treatment Market Share by Application (2017-2028)
9.4 Latin America Mucopolysaccharidosis (MPS) Treatment Market Size by Country
9.4.1 Latin America Mucopolysaccharidosis (MPS) Treatment Market Size by Country (2017-2022)
9.4.2 Latin America Mucopolysaccharidosis (MPS) Treatment Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Mucopolysaccharidosis (MPS) Treatment Market Size (2017-2028)
10.2 Middle East & Africa Mucopolysaccharidosis (MPS) Treatment Market Size by Type
10.2.1 Middle East & Africa Mucopolysaccharidosis (MPS) Treatment Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Mucopolysaccharidosis (MPS) Treatment Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Mucopolysaccharidosis (MPS) Treatment Market Share by Type (2017-2028)
10.3 Middle East & Africa Mucopolysaccharidosis (MPS) Treatment Market Size by Application
10.3.1 Middle East & Africa Mucopolysaccharidosis (MPS) Treatment Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Mucopolysaccharidosis (MPS) Treatment Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Mucopolysaccharidosis (MPS) Treatment Market Share by Application (2017-2028)
10.4 Middle East & Africa Mucopolysaccharidosis (MPS) Treatment Market Size by Country
10.4.1 Middle East & Africa Mucopolysaccharidosis (MPS) Treatment Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Mucopolysaccharidosis (MPS) Treatment Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Sanofi
11.1.1 Sanofi Company Details
11.1.2 Sanofi Business Overview
11.1.3 Sanofi Mucopolysaccharidosis (MPS) Treatment Introduction
11.1.4 Sanofi Revenue in Mucopolysaccharidosis (MPS) Treatment Business (2017-2022)
11.1.5 Sanofi Recent Developments
11.2 Shire (Takeda)
11.2.1 Shire (Takeda) Company Details
11.2.2 Shire (Takeda) Business Overview
11.2.3 Shire (Takeda) Mucopolysaccharidosis (MPS) Treatment Introduction
11.2.4 Shire (Takeda) Revenue in Mucopolysaccharidosis (MPS) Treatment Business (2017-2022)
11.2.5 Shire (Takeda) Recent Developments
11.3 BioMarin Pharmaceutical
11.3.1 BioMarin Pharmaceutical Company Details
11.3.2 BioMarin Pharmaceutical Business Overview
11.3.3 BioMarin Pharmaceutical Mucopolysaccharidosis (MPS) Treatment Introduction
11.3.4 BioMarin Pharmaceutical Revenue in Mucopolysaccharidosis (MPS) Treatment Business (2017-2022)
11.3.5 BioMarin Pharmaceutical Recent Developments
11.4 Esteve
11.4.1 Esteve Company Details
11.4.2 Esteve Business Overview
11.4.3 Esteve Mucopolysaccharidosis (MPS) Treatment Introduction
11.4.4 Esteve Revenue in Mucopolysaccharidosis (MPS) Treatment Business (2017-2022)
11.4.5 Esteve Recent Developments
11.5 REGENXBIO Inc
11.5.1 REGENXBIO Inc Company Details
11.5.2 REGENXBIO Inc Business Overview
11.5.3 REGENXBIO Inc Mucopolysaccharidosis (MPS) Treatment Introduction
11.5.4 REGENXBIO Inc Revenue in Mucopolysaccharidosis (MPS) Treatment Business (2017-2022)
11.5.5 REGENXBIO Inc Recent Developments
11.6 Sangamo Therapeutics
11.6.1 Sangamo Therapeutics Company Details
11.6.2 Sangamo Therapeutics Business Overview
11.6.3 Sangamo Therapeutics Mucopolysaccharidosis (MPS) Treatment Introduction
11.6.4 Sangamo Therapeutics Revenue in Mucopolysaccharidosis (MPS) Treatment Business (2017-2022)
11.6.5 Sangamo Therapeutics Recent Developments
11.7 Ultragenyx Pharmaceutical
11.7.1 Ultragenyx Pharmaceutical Company Details
11.7.2 Ultragenyx Pharmaceutical Business Overview
11.7.3 Ultragenyx Pharmaceutical Mucopolysaccharidosis (MPS) Treatment Introduction
11.7.4 Ultragenyx Pharmaceutical Revenue in Mucopolysaccharidosis (MPS) Treatment Business (2017-2022)
11.7.5 Ultragenyx Pharmaceutical Recent Developments
11.8 Abeona Therapeutics
11.8.1 Abeona Therapeutics Company Details
11.8.2 Abeona Therapeutics Business Overview
11.8.3 Abeona Therapeutics Mucopolysaccharidosis (MPS) Treatment Introduction
11.8.4 Abeona Therapeutics Revenue in Mucopolysaccharidosis (MPS) Treatment Business (2017-2022)
11.8.5 Abeona Therapeutics Recent Developments
11.9 ArmaGen
11.9.1 ArmaGen Company Details
11.9.2 ArmaGen Business Overview
11.9.3 ArmaGen Mucopolysaccharidosis (MPS) Treatment Introduction
11.9.4 ArmaGen Revenue in Mucopolysaccharidosis (MPS) Treatment Business (2017-2022)
11.9.5 ArmaGen Recent Developments
11.10 Eloxx Pharmaceuticals
11.10.1 Eloxx Pharmaceuticals Company Details
11.10.2 Eloxx Pharmaceuticals Business Overview
11.10.3 Eloxx Pharmaceuticals Mucopolysaccharidosis (MPS) Treatment Introduction
11.10.4 Eloxx Pharmaceuticals Revenue in Mucopolysaccharidosis (MPS) Treatment Business (2017-2022)
11.10.5 Eloxx Pharmaceuticals Recent Developments
11.11 Inventiva
11.11.1 Inventiva Company Details
11.11.2 Inventiva Business Overview
11.11.3 Inventiva Mucopolysaccharidosis (MPS) Treatment Introduction
11.11.4 Inventiva Revenue in Mucopolysaccharidosis (MPS) Treatment Business (2017-2022)
11.11.5 Inventiva Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Mucopolysaccharidosis (MPS) Treatment Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Stem Cell Therapies
Table 3. Key Players of Enzyme Replacement Therapies
Table 4. Global Mucopolysaccharidosis (MPS) Treatment Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 5. Global Mucopolysaccharidosis (MPS) Treatment Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 6. Global Mucopolysaccharidosis (MPS) Treatment Market Size by Region (2017-2022) & (US$ Million)
Table 7. Global Mucopolysaccharidosis (MPS) Treatment Market Share by Region (2017-2022)
Table 8. Global Mucopolysaccharidosis (MPS) Treatment Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 9. Global Mucopolysaccharidosis (MPS) Treatment Market Share by Region (2023-2028)
Table 10. Mucopolysaccharidosis (MPS) Treatment Market Trends
Table 11. Mucopolysaccharidosis (MPS) Treatment Market Drivers
Table 12. Mucopolysaccharidosis (MPS) Treatment Market Challenges
Table 13. Mucopolysaccharidosis (MPS) Treatment Market Restraints
Table 14. Global Mucopolysaccharidosis (MPS) Treatment Revenue by Players (2017-2022) & (US$ Million)
Table 15. Global Mucopolysaccharidosis (MPS) Treatment Revenue Share by Players (2017-2022)
Table 16. Global Top Mucopolysaccharidosis (MPS) Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Mucopolysaccharidosis (MPS) Treatment as of 2021)
Table 17. Ranking of Global Top Mucopolysaccharidosis (MPS) Treatment Companies by Revenue (US$ Million) in 2021
Table 18. Global 5 Largest Players Market Share by Mucopolysaccharidosis (MPS) Treatment Revenue (CR5 and HHI) & (2017-2022)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Mucopolysaccharidosis (MPS) Treatment Product Solution and Service
Table 21. Date of Enter into Mucopolysaccharidosis (MPS) Treatment Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Mucopolysaccharidosis (MPS) Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 24. Global Mucopolysaccharidosis (MPS) Treatment Revenue Market Share by Type (2017-2022)
Table 25. Global Mucopolysaccharidosis (MPS) Treatment Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 26. Global Mucopolysaccharidosis (MPS) Treatment Revenue Market Share by Type (2023-2028)
Table 27. Global Mucopolysaccharidosis (MPS) Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 28. Global Mucopolysaccharidosis (MPS) Treatment Revenue Share by Application (2017-2022)
Table 29. Global Mucopolysaccharidosis (MPS) Treatment Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 30. Global Mucopolysaccharidosis (MPS) Treatment Revenue Share by Application (2023-2028)
Table 31. North America Mucopolysaccharidosis (MPS) Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 32. North America Mucopolysaccharidosis (MPS) Treatment Market Size by Type (2023-2028) & (US$ Million)
Table 33. North America Mucopolysaccharidosis (MPS) Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 34. North America Mucopolysaccharidosis (MPS) Treatment Market Size by Application (2023-2028) & (US$ Million)
Table 35. North America Mucopolysaccharidosis (MPS) Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 36. North America Mucopolysaccharidosis (MPS) Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 37. Europe Mucopolysaccharidosis (MPS) Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 38. Europe Mucopolysaccharidosis (MPS) Treatment Market Size by Type (2023-2028) & (US$ Million)
Table 39. Europe Mucopolysaccharidosis (MPS) Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 40. Europe Mucopolysaccharidosis (MPS) Treatment Market Size by Application (2023-2028) & (US$ Million)
Table 41. Europe Mucopolysaccharidosis (MPS) Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 42. Europe Mucopolysaccharidosis (MPS) Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 43. Asia Pacific Mucopolysaccharidosis (MPS) Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 44. Asia Pacific Mucopolysaccharidosis (MPS) Treatment Market Size by Type (2023-2028) & (US$ Million)
Table 45. Asia Pacific Mucopolysaccharidosis (MPS) Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 46. Asia Pacific Mucopolysaccharidosis (MPS) Treatment Market Size by Application (2023-2028) & (US$ Million)
Table 47. Asia Pacific Mucopolysaccharidosis (MPS) Treatment Market Size by Region (2017-2022) & (US$ Million)
Table 48. Asia Pacific Mucopolysaccharidosis (MPS) Treatment Market Size by Region (2023-2028) & (US$ Million)
Table 49. Latin America Mucopolysaccharidosis (MPS) Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 50. Latin America Mucopolysaccharidosis (MPS) Treatment Market Size by Type (2023-2028) & (US$ Million)
Table 51. Latin America Mucopolysaccharidosis (MPS) Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 52. Latin America Mucopolysaccharidosis (MPS) Treatment Market Size by Application (2023-2028) & (US$ Million)
Table 53. Latin America Mucopolysaccharidosis (MPS) Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 54. Latin America Mucopolysaccharidosis (MPS) Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 55. Middle East and Africa Mucopolysaccharidosis (MPS) Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 56. Middle East and Africa Mucopolysaccharidosis (MPS) Treatment Market Size by Type (2023-2028) & (US$ Million)
Table 57. Middle East and Africa Mucopolysaccharidosis (MPS) Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 58. Middle East and Africa Mucopolysaccharidosis (MPS) Treatment Market Size by Application (2023-2028) & (US$ Million)
Table 59. Middle East and Africa Mucopolysaccharidosis (MPS) Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 60. Middle East and Africa Mucopolysaccharidosis (MPS) Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 61. Sanofi Company Details
Table 62. Sanofi Business Overview
Table 63. Sanofi Mucopolysaccharidosis (MPS) Treatment Product
Table 64. Sanofi Revenue in Mucopolysaccharidosis (MPS) Treatment Business (2017-2022) & (US$ Million)
Table 65. Sanofi Recent Developments
Table 66. Shire (Takeda) Company Details
Table 67. Shire (Takeda) Business Overview
Table 68. Shire (Takeda) Mucopolysaccharidosis (MPS) Treatment Product
Table 69. Shire (Takeda) Revenue in Mucopolysaccharidosis (MPS) Treatment Business (2017-2022) & (US$ Million)
Table 70. Shire (Takeda) Recent Developments
Table 71. BioMarin Pharmaceutical Company Details
Table 72. BioMarin Pharmaceutical Business Overview
Table 73. BioMarin Pharmaceutical Mucopolysaccharidosis (MPS) Treatment Product
Table 74. BioMarin Pharmaceutical Revenue in Mucopolysaccharidosis (MPS) Treatment Business (2017-2022) & (US$ Million)
Table 75. BioMarin Pharmaceutical Recent Developments
Table 76. Esteve Company Details
Table 77. Esteve Business Overview
Table 78. Esteve Mucopolysaccharidosis (MPS) Treatment Product
Table 79. Esteve Revenue in Mucopolysaccharidosis (MPS) Treatment Business (2017-2022) & (US$ Million)
Table 80. Esteve Recent Developments
Table 81. REGENXBIO Inc Company Details
Table 82. REGENXBIO Inc Business Overview
Table 83. REGENXBIO Inc Mucopolysaccharidosis (MPS) Treatment Product
Table 84. REGENXBIO Inc Revenue in Mucopolysaccharidosis (MPS) Treatment Business (2017-2022) & (US$ Million)
Table 85. REGENXBIO Inc Recent Developments
Table 86. Sangamo Therapeutics Company Details
Table 87. Sangamo Therapeutics Business Overview
Table 88. Sangamo Therapeutics Mucopolysaccharidosis (MPS) Treatment Product
Table 89. Sangamo Therapeutics Revenue in Mucopolysaccharidosis (MPS) Treatment Business (2017-2022) & (US$ Million)
Table 90. Sangamo Therapeutics Recent Developments
Table 91. Ultragenyx Pharmaceutical Company Details
Table 92. Ultragenyx Pharmaceutical Business Overview
Table 93. Ultragenyx Pharmaceutical Mucopolysaccharidosis (MPS) Treatment Product
Table 94. Ultragenyx Pharmaceutical Revenue in Mucopolysaccharidosis (MPS) Treatment Business (2017-2022) & (US$ Million)
Table 95. Ultragenyx Pharmaceutical Recent Developments
Table 96. Abeona Therapeutics Company Details
Table 97. Abeona Therapeutics Business Overview
Table 98. Abeona Therapeutics Mucopolysaccharidosis (MPS) Treatment Product
Table 99. Abeona Therapeutics Revenue in Mucopolysaccharidosis (MPS) Treatment Business (2017-2022) & (US$ Million)
Table 100. Abeona Therapeutics Recent Developments
Table 101. ArmaGen Company Details
Table 102. ArmaGen Business Overview
Table 103. ArmaGen Mucopolysaccharidosis (MPS) Treatment Product
Table 104. ArmaGen Revenue in Mucopolysaccharidosis (MPS) Treatment Business (2017-2022) & (US$ Million)
Table 105. ArmaGen Recent Developments
Table 106. Eloxx Pharmaceuticals Company Details
Table 107. Eloxx Pharmaceuticals Business Overview
Table 108. Eloxx Pharmaceuticals Mucopolysaccharidosis (MPS) Treatment Product
Table 109. Eloxx Pharmaceuticals Revenue in Mucopolysaccharidosis (MPS) Treatment Business (2017-2022) & (US$ Million)
Table 110. Eloxx Pharmaceuticals Recent Developments
Table 111. Inventiva Company Details
Table 112. Inventiva Business Overview
Table 113. Inventiva Mucopolysaccharidosis (MPS) Treatment Product
Table 114. Inventiva Revenue in Mucopolysaccharidosis (MPS) Treatment Business (2017-2022) & (US$ Million)
Table 115. Inventiva Recent Developments
Table 116. Research Programs/Design for This Report
Table 117. Key Data Information from Secondary Sources
Table 118. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Mucopolysaccharidosis (MPS) Treatment Market Share by Type: 2021 VS 2028
Figure 2. Stem Cell Therapies Features
Figure 3. Enzyme Replacement Therapies Features
Figure 4. Global Mucopolysaccharidosis (MPS) Treatment Market Share by Application: 2021 VS 2028
Figure 5. Hospitals Case Studies
Figure 6. Clinics Case Studies
Figure 7. Homecare Case Studies
Figure 8. Mucopolysaccharidosis (MPS) Treatment Report Years Considered
Figure 9. Global Mucopolysaccharidosis (MPS) Treatment Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 10. Global Mucopolysaccharidosis (MPS) Treatment Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 11. Global Mucopolysaccharidosis (MPS) Treatment Market Share by Region: 2021 VS 2028
Figure 12. Global Mucopolysaccharidosis (MPS) Treatment Market Share by Players in 2021
Figure 13. Global Top Mucopolysaccharidosis (MPS) Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Mucopolysaccharidosis (MPS) Treatment as of 2021)
Figure 14. The Top 10 and 5 Players Market Share by Mucopolysaccharidosis (MPS) Treatment Revenue in 2021
Figure 15. North America Mucopolysaccharidosis (MPS) Treatment Market Size YoY (2017-2028) & (US$ Million)
Figure 16. North America Mucopolysaccharidosis (MPS) Treatment Market Size Market Share by Type (2017-2028)
Figure 17. North America Mucopolysaccharidosis (MPS) Treatment Market Size Market Share by Application (2017-2028)
Figure 18. North America Mucopolysaccharidosis (MPS) Treatment Market Size Share by Country (2017-2028)
Figure 19. United States Mucopolysaccharidosis (MPS) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 20. Canada Mucopolysaccharidosis (MPS) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 21. Europe Mucopolysaccharidosis (MPS) Treatment Market Size YoY (2017-2028) & (US$ Million)
Figure 22. Europe Mucopolysaccharidosis (MPS) Treatment Market Size Market Share by Type (2017-2028)
Figure 23. Europe Mucopolysaccharidosis (MPS) Treatment Market Size Market Share by Application (2017-2028)
Figure 24. Europe Mucopolysaccharidosis (MPS) Treatment Market Size Share by Country (2017-2028)
Figure 25. Germany Mucopolysaccharidosis (MPS) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. France Mucopolysaccharidosis (MPS) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. U.K. Mucopolysaccharidosis (MPS) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. Italy Mucopolysaccharidosis (MPS) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Russia Mucopolysaccharidosis (MPS) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Nordic Countries Mucopolysaccharidosis (MPS) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Asia-Pacific Mucopolysaccharidosis (MPS) Treatment Market Size YoY (2017-2028) & (US$ Million)
Figure 32. Asia Pacific Mucopolysaccharidosis (MPS) Treatment Market Size Market Share by Type (2017-2028)
Figure 33. Asia Pacific Mucopolysaccharidosis (MPS) Treatment Market Size Market Share by Application (2017-2028)
Figure 34. Asia Pacific Mucopolysaccharidosis (MPS) Treatment Market Size Share by Region (2017-2028)
Figure 35. China Mucopolysaccharidosis (MPS) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. Japan Mucopolysaccharidosis (MPS) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. South Korea Mucopolysaccharidosis (MPS) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Southeast Asia Mucopolysaccharidosis (MPS) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. India Mucopolysaccharidosis (MPS) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Australia Mucopolysaccharidosis (MPS) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
Figure 41. Latin America Mucopolysaccharidosis (MPS) Treatment Market Size YoY (2017-2028) & (US$ Million)
Figure 42. Latin America Mucopolysaccharidosis (MPS) Treatment Market Size Market Share by Type (2017-2028)
Figure 43. Latin America Mucopolysaccharidosis (MPS) Treatment Market Size Market Share by Application (2017-2028)
Figure 44. Latin America Mucopolysaccharidosis (MPS) Treatment Market Size Share by Country (2017-2028)
Figure 45. Mexico Mucopolysaccharidosis (MPS) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 46. Brazil Mucopolysaccharidosis (MPS) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 47. Middle East & Africa Mucopolysaccharidosis (MPS) Treatment Market Size YoY (2017-2028) & (US$ Million)
Figure 48. Middle East and Africa Mucopolysaccharidosis (MPS) Treatment Market Size Market Share by Type (2017-2028)
Figure 49. Middle East and Africa Mucopolysaccharidosis (MPS) Treatment Market Size Market Share by Application (2017-2028)
Figure 50. Middle East and Africa Mucopolysaccharidosis (MPS) Treatment Market Size Share by Country (2017-2028)
Figure 51. Turkey Mucopolysaccharidosis (MPS) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 52. Saudi Arabia Mucopolysaccharidosis (MPS) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 53. UAE Mucopolysaccharidosis (MPS) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 54. Sanofi Revenue Growth Rate in Mucopolysaccharidosis (MPS) Treatment Business (2017-2022)
Figure 55. Shire (Takeda) Revenue Growth Rate in Mucopolysaccharidosis (MPS) Treatment Business (2017-2022)
Figure 56. BioMarin Pharmaceutical Revenue Growth Rate in Mucopolysaccharidosis (MPS) Treatment Business (2017-2022)
Figure 57. Esteve Revenue Growth Rate in Mucopolysaccharidosis (MPS) Treatment Business (2017-2022)
Figure 58. REGENXBIO Inc Revenue Growth Rate in Mucopolysaccharidosis (MPS) Treatment Business (2017-2022)
Figure 59. Sangamo Therapeutics Revenue Growth Rate in Mucopolysaccharidosis (MPS) Treatment Business (2017-2022)
Figure 60. Ultragenyx Pharmaceutical Revenue Growth Rate in Mucopolysaccharidosis (MPS) Treatment Business (2017-2022)
Figure 61. Abeona Therapeutics Revenue Growth Rate in Mucopolysaccharidosis (MPS) Treatment Business (2017-2022)
Figure 62. ArmaGen Revenue Growth Rate in Mucopolysaccharidosis (MPS) Treatment Business (2017-2022)
Figure 63. Eloxx Pharmaceuticals Revenue Growth Rate in Mucopolysaccharidosis (MPS) Treatment Business (2017-2022)
Figure 64. Inventiva Revenue Growth Rate in Mucopolysaccharidosis (MPS) Treatment Business (2017-2022)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
Buy
